Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e098a814c080fee04806866473ca776 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 |
filingDate |
2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb0ea121ecebdb0d8dd85494661e523a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ee7d6c09792362752e85b14920d6b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a4e27dd6ec2ea70c13f30fcf798a5e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7e33ded860bfbcf2466e25d97a6ba6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efc6554f6867f0909ca8ed19d64289b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab8403d651b9dd3e4de2ec059a4861c |
publicationDate |
2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2592231-C2 |
titleOfInvention |
Methods of applying (+)-1,4-dihydro-7-[(3s, 4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(thiazolyl)-1,8-naphthiridine-3-carboxylic acid for cancer treatment |
abstract |
FIELD: medicine. n SUBSTANCE: to treat acute myologenic leukaemia (+)-1,4-dihydro-7-[(3S, 4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(thiazolyl)-1,8-naphthiridine-3-carboxylic acid in doses from approximately 30 mg/m 2 to less than 50 mg/m 2 and from more than 90 to 100 mg/m 2 is introduced to patient, suffering from acute myelogenic leukaemia. n EFFECT: treatment of acute myelogenic leukaemia with introduction of said compound in effective and safe doses. n 11 cl, 20 dwg, 16 tbl, 11 ex |
priorityDate |
2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |